Jump to content
Powered by

Red biotechnology

The latest articles, press releases and dossiers on red biotechnology in Baden-Württemberg

  • Dossier - 09/07/2012

    More practical relevance, shorter courses and courses that are compatible across Europe – when the decision to implement the bachelor’s and master’s system was made in Germany in 1999, there were high expectations and hopes for the positive changes to come. The question is, have these expectations been met? The time is now ripe for universities and companies to review the progress that has been made in achieving the goals of the Bologna…

  • Dossier - 10/10/2011

    Biotechnology companies have always had international ties: they employ cutting-edge technologies and market the discoveries and developments of researchers around the world. Rapid innovation cycles and rapid technological developments force companies to undertake costly R&D as well as market their products and/or services across national borders.

  • Dossier - 19/09/2011

    Social network services are springing up like mushrooms; everybody seems to be talking about ‘Web 2.0’ or ‘Podcast’. The life sciences are also starting to use the new communication media for their purposes. Social network services are online platforms with a representation of each individual user who links up with a number of different social networks composed of other users. Terms like Web 2.0 and Podcast are commonly used and the World Wide…

  • Dossier - 18/10/2010

    Hardware and software applications have become an integral part of the everyday life of life sciences researchers, developers and service providers. It is impossible to imagine life science applications without effective hardware and software applications – from computer-assisted drug screening to the automatic production of biosensors for rapid, mobile, purse-size bacterial test devices. Trends such as automation and miniaturisation lead to ever…

  • Dossier - 09/08/2010

    Biomolecules such as peptides and nucleic acids can nowadays be synthesised relatively quickly and inexpensively. In addition, great progress has been made in the development of methods enabling the directed mutagenesis in microorganisms. These two developments have boosted the design of new, and the reorganisation of known, molecules. Moreover, these help in the utilisation of certain molecule functions in research and in the industrial…

  • Dossier - 14/06/2010

    Synthetic biology focuses on the development of biological systems with new defined characteristics assembled according to the principles of engineering. Synthetic biology has the potential to be used for a broad range of applications and has solutions in store for major problems of the future. It also fuels fears that human beings are playing the role of creators and going beyond natural boundaries.

  • Dossier - 16/07/2009

    According to statistics from the European Patent Office a total of 1065 biotechnological patents were filed in 2007 by inventors based in Germany. This puts Germany second behind the USA. In the coming years experts expect that a much larger number of biotech patents will be filed. For life sciences inventors the registration of patents quite often represents a real challenge. People entering the world of patents and licences are faced with a…

  • Dossier - 25/05/2009

    Founding a company is a very complex process especially in knowledge-intensive sectors such as biotechnology. Turning a vague business idea into a successful company is characterised by different phases that place great demands on the qualifications and learning aptitudes of the company founders. Financing and economic organisation often means that company founders have to enter completely unknown new territory.

  • Dossier - 15/07/2008

    Science needs publicity. Publicly funded research has to account for its projects internally as well as externally. In the past accounting for projects was a matter dealt with in courtly or academic circles today the forum is research journals. This internal communication seldom reaches the public however external communication seeks out the wider lay audience - for many reasons.

Website address: https://www.gesundheitsindustrie-bw.de/en/article/biotech